Alaska Department of Health confirmed first fatal case of Alaskapox virus
On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…
-
-
FDA authorized Florida’s Drug Importation Program
On Jan. 5, 2024, the U.S. Food and Drug Administration (FDA) authorized Florida’s Agency for Health Care Administration’s…
-
Artificial Intelligence | Biotechnology | Imaging | Medical Device | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Therapeutics
University of Michigan Center for Innovation breaks ground
On Dec. 14, 2023, the University of Michigan Center for Innovation (UMCI) in Detroit broke ground with high-energy…
-
ZURZUVAE (zuranolone) CIV, a landmark treatment for women with postpartum Depression, available in the U.S.
On Dec. 14, 2023, Biogen and Sage Therapeutics announced ZURZUVAE (zuranolone) 50 mg (two 25 mg capsules per…
-
Biotechnology | Clinical Research | COVID-19 | FDA | Infectious Disease | Medicine | NIH | Therapeutics | Vaccine
FDA issued final guidance on developing drugs for COVID-19 treatment and preventionﾠ
On Nov. 22, 2023, the U.S. Food and Drug Administration (FDA) issued the final guidance COVID-19: Developing Drugs…
-
The White House lanuched Initiative on Women’s Health Research
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenﾒs Health Research, an effort led…
-
Biotechnology | Disease | Medicine | NIH | Therapeutics
NIH awarded $50.3 million for ‘multi-omics’ research on human health and disease
On Sept. 12, 2023, the National Institutes of Health announced it was establishing the Multi-Omics for Health and…
-
NIAID-funded study traced evolution of Malaria drug resistance in East Africa
On Aug. 24, 2023, the National Institute of Allergy and Infectious Diseases (NIAID) reported that emerging resistance to…
-
COVID-19 vaccination and boosting during pregnancy benefits pregnant women and newborns
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
-
Biotechnology | Disease | HIV | Infectious Disease | Influenza | Measles | Medicine | Plague | Polio | Therapeutics | Vaccine
UKHSA unveils VDEC in ‘step change’ for UK’s growing vaccine capabilities
On Aug. 7, 2023, the UK Health Security Agency (UKHSA) unveiled its world-leading Vaccine Development and Evaluation Centre…
-
Biotechnology | Medicine | NIH | Therapeutics
Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
On Aug. 7, 2023, a National Institute of Health (NIH) supported study found that in 2021, an estimated…
-
Biotechnology | Disease | FDA | Medicine | Therapeutics
U.S. FDA approved first gene therapy for treatment of patients with Duchenne Muscular Dystrophy
On Jun. 22, 2023, the U.S. Food and Drug Administration (FDA) approved Sarepta Therapeutics’s Elevidys, the first gene…
-
U.S. FDA approved new class of medicines to treat pediatric type 2 diabetes
On Jun. 20, 2023, the U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim’s Jardiance (empagliflozin) and Synjardy…
-
CIRM invested $10 million to build California Cell and Gene Therapy Manufacturing Network
On May 31, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $10 million to five facilities as…
-
NanoViricides announced licensing agreement with Karveer Meditech to commercialize COVID drugs
On Apr. 4, 2023, NanoViricides announced that it had executed a license agreement with Karveer Meditech, Kolhapur, India,…
-
Biotechnology | Diagnostics | Medicine | NIH | Oncology | Radiology | Therapeutics | Women's Health
U.S. Department of Health and Human Services released National Cancer Plan
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
-
Federal investment to increase Canada’s capacity to develop and manufacture critical medicines
On Mar. 17, 2023, PrairiesCan announced $80,514,000 over five years to support the Canadian Critical Drug Initiative and…
-
Amphastar Pharmaceuticals received FDA approval for Naloxone hydrochloride nasal spray
On Mar. 8, 2023, Amphastar Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had granted approval…
-
Risk of developing heart failure much higher in rural areas vs. urban
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…
-
Biotechnology | COVID-19 | Medicine | Vaccine
Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster demonstrating improved immune response against Omicron sublineages
On Nov. 18, 2022, Pfizer and BioNTech announced results from an analysis examining the immune response induced by…
-
The Nobel Prize in Physiology or Medicine awarded to Svante Paabo “for his discoveries concerning the genomes of extinct hominins and human evolution”
On Oct. 3, 2022, the Nobel Prize in Physiology or Medicine was awarded to Svante Paabo “for his…
-
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Medicine | Nanotechnology | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
U.S. Biotechnology & Biomanufacturing Initiative
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
-
Biotechnology | Diagnostics | Disease | Medical Device | Medicine | Non-Profit Research | Therapeutics
University of Victoria BioInnovation Hub to enhance collaboration in BC’s life sciences sector
On Aug. 31, 2022, a new front-door to the University of Victoria opened to advance health and life…
-
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 Vacations Redux
COVID-19 Vacations Redux iIlustrates once again the pits and perils vacation travelers face as they begin their Summer…
-
Whole Health School of Medicine to become Alice L. Walton School of Medicine
On Jun. 30, 2022, Alice L. Walton School of Medicine announces the next steps in its development, including…
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Medicine | Neurology | NIH | Non-Profit Research | Olfactory | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 Wheel of Fortune
Play the COVID-19 Wheel of Fortune and see how lucky you are! You have two wheels to choose…
-
Biotechnology | Disease | Medicine | NIH | Ophthalmogy | Therapeutics
NIH study confirmed benefit of supplements for slowing age-related macular degeneration
On Jun. 2, 2022, the National Institutes of Health (NIH) reported that the Age-Related Eye Disease Studies (AREDS…
-
Artificial Intelligence | Biotechnology | Genomics | Infectious Disease | Medicine | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics
The Advanced Research Projects Agency for Health (ARPA-H) was established
On May 25, 2022, the Health and Human Services agency (HHS) announced the formal establishment of the Advanced…
-
Merck and Ridgeback reported data demonstrating treatment with LAGEVRIO (molnupiravir) associated with more rapid elimination of SARS-CoV-2 than placebo
On Apr. 1, 2022, Merck and Ridgeback Biotherapeutics announced data evaluating LAGEVRIO (molnupiravir), an investigational oral antiviral COVID-19…
-
Researchers generated the first complete, gapless sequence of a human genome
On Mar. 31, 2022, researchers announced they have created a complete, gap-free sequence of the roughly 3 billion…
